Radiation and pulmonary fibrosis

Radiation-induced pulmonary fibrosis—tissue scarring that can permanently impair lung function—limits the delivery of therapeutic radiation doses to non-small cell lung cancer.

To develop strategies for preventing or reducing , Michael Freeman, Ph.D., and colleagues are exploring the cell types and factors that contribute to the radiation-induced fibrotic response.

The investigators previously showed that loss of the transcription factor Nrf2 increases susceptibility to pulmonary fibrosis. They now show that thoracic (chest) radiation of mice causes a loss of alveolar type 2 cells and that this loss is enhanced in mice lacking Nrf2.

The researchers found that a specific stem/progenitor cell population was inhibited following radiation in mice missing Nrf2, and that alveolar type 2 in these mice were more likely to change into myofibroblasts—a cell type implicated in fibrosis.

The findings, reported in the November Free Radical Biology and Medicine, demonstrate that Nrf2 participates in stem cell mobilization and helps maintain the alveolar type 2 cell reparative process in injured lungs.


Explore further

New tools to combat kidney fibrosis

More information: Geri Traver et al. Loss of Nrf2 promotes alveolar type 2 cell loss in irradiated, fibrotic lung, Free Radical Biology and Medicine (2017). DOI: 10.1016/j.freeradbiomed.2017.08.026
Citation: Radiation and pulmonary fibrosis (2017, November 16) retrieved 13 November 2019 from https://medicalxpress.com/news/2017-11-pulmonary-fibrosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments